About Us

About Us

GBI Health, founded in 2002 and headquartered in Shanghai, is one of China’s leading healthcare data and intelligence providers. Driven by data and technology, we deliver comprehensive data intelligence, industry insights, and decision support across the full lifecycle of pharmaceuticals and medical devices. Our solutions serve pharmaceutical and medical device companies, as well as healthcare industry service providers, helping them make more informed decisions across portfolio strategy, product development, market access, and medical affairs.

For more than two decades, GBI Health has been a trusted long-term partner to over 95% of multinational pharmaceutical companies operating in China, as well as leading domestic pharmaceutical companies and healthcare consulting firms.

What We Offer

  • Global Drug Intelligence - GBI SOURCE integrates full-lifecycle drug data from preclinical development through post-marketing, covering pipeline assets, competitive landscapes, market access, and industry news to support better-informed R&D and commercialization decisions.
  • Market Access & Pricing Strategy - GBI SOURCE provides extensive data coverage across key market access channels in China, including the National Reimbursement Drug List (NRDL), public procurement and tendering, Huiminbao (commercial health insurance), and Patient Assistance Programs (PAPs), supporting data-driven pricing and market access strategies.
  • HCP & Researcher Insights - GBI METRIX leverages a proprietary tagging and evaluation framework to build HCP360 profiles for more than 5 million researchers and HCPs, supporting KOL mapping, segmentation and engagement.
  • Medical Device Intelligence - GBI DEVINT integrates regulatory filing, clinical trial, and procurement data to help medical device companies evaluate competitive dynamics and identify market opportunities.
  • Tailored Consulting Services - Drawing on deep industry expertise and comprehensive data assets, we provide tailored support for competitive landscape analysis, clinical development research, and other strategic projects.

Why GBI Health

  • Comprehensive Data Assets

    Our global data collection capabilities span pharmaceuticals, medical devices, researchers, clinical trials, and more, with continuous updates to ensure timely and reliable intelligence.

  • Rigorous Methodology

    Our proprietary standardized evaluation frameworks and advanced AI analytics transform fragmented data into actionable commercial insights.

  • Proven Track Record

    Our track record spans more than two decades and includes long-standing partnerships with over 95% of leading pharmaceutical companies in China.

See the Whole Landscape Shape What's Next in Pharma

GBI Health unites global pharmaceutical data, AI capabilities and industry expertise to deliver future-ready solutions across the entire product lifecycle.

Contact Us